Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 3-year Analysis of the KEEPsAKE 1 and 2 Trials. J of Skin [Internet]. 2023 Nov. 13 [cited 2025 May 18];7(6):s249. Available from: https://skin.dermsquared.com/skin/article/view/2396